Document is current

Article History

Received: 26 October 2022

Revised: 8 February 2023

Accepted: 20 February 2023

First Online: 2 March 2023

Declarations

:

: The S.AGES study was approved by the University of Angers Ethics Committee and the <i>Comité Consultative sur le Traitement de l'Information en matière de Recherche dans le domaine de la Santé</i> (CCTIRS): No. 07207 dated 17 May 2013. It has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.All included patients gave their written consent to participate in the study.

: The authors claimed to have no conflicts of interest related to the present study.Within the previous 5 years, FM claimed to be or have been coordinator or investigator of studies promoted by AstraZeneca, Respmed-Narval, Philips-Respironics; to have been consultant for ADEP-Assistance; to have been invited to congress by AstraZeneca, Boehringer-Ingelheim, GSK, Novartis, ADEP-Assistance, France-Oxygène, Orkyn, Philips-Respironics, Respmed-Narval, and SOS Oxygen; to have received compensation as congress speaker by AstraZeneca, Boehringer-Ingelheim, Novartis, Philips-Respironics and Respmed-Narval.